⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for unresectable gallbladder carcinoma

Every month we try and update this database with for unresectable gallbladder carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)NCT05564403
Recurrent Bilia...
Recurrent Dista...
Recurrent Gallb...
Recurrent Intra...
Stage III Dista...
Stage III Hilar...
Stage III Intra...
Stage IV Distal...
Stage IV Hilar ...
Stage IV Intrah...
Unresectable Bi...
Unresectable Di...
Unresectable Ga...
Unresectable In...
Binimetinib
Biopsy
Biospecimen Col...
Bone Scan
Computed Tomogr...
Echocardiograph...
Fluorouracil
Leucovorin Calc...
Magnetic Resona...
Multigated Acqu...
Oxaliplatin
18 Years - National Cancer Institute (NCI)
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder CancerNCT03257761
Extrahepatic Bi...
Gallbladder Ade...
Metastatic Panc...
Recurrent Chola...
Recurrent Gallb...
Recurrent Hepat...
Recurrent Intra...
Recurrent Pancr...
Stage III Gallb...
Stage III Hepat...
Stage III Intra...
Stage III Pancr...
Stage IIIA Gall...
Stage IIIA Hepa...
Stage IIIB Gall...
Stage IIIB Hepa...
Stage IIIC Hepa...
Stage IV Gallbl...
Stage IV Hepato...
Stage IV Pancre...
Stage IVA Gallb...
Stage IVA Hepat...
Stage IVA Intra...
Stage IVB Gallb...
Stage IVB Hepat...
Stage IVB Intra...
Unresectable Ga...
Unresectable Pa...
Durvalumab
Guadecitabine
18 Years - University of Southern California
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract CancersNCT03768414
Stage III Dista...
Stage III Gallb...
Stage III Intra...
Stage IIIA Dist...
Stage IIIA Gall...
Stage IIIA Intr...
Stage IIIB Dist...
Stage IIIB Gall...
Stage IIIB Intr...
Stage IV Distal...
Stage IV Gallbl...
Stage IV Intrah...
Stage IVA Gallb...
Stage IVB Gallb...
Unresectable Ex...
Unresectable Ga...
Unresectable In...
Cisplatin
Gemcitabine Hyd...
Nab-paclitaxel
18 Years - SWOG Cancer Research Network
Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)NCT05564403
Recurrent Bilia...
Recurrent Dista...
Recurrent Gallb...
Recurrent Intra...
Stage III Dista...
Stage III Hilar...
Stage III Intra...
Stage IV Distal...
Stage IV Hilar ...
Stage IV Intrah...
Unresectable Bi...
Unresectable Di...
Unresectable Ga...
Unresectable In...
Binimetinib
Biopsy
Biospecimen Col...
Bone Scan
Computed Tomogr...
Echocardiograph...
Fluorouracil
Leucovorin Calc...
Magnetic Resona...
Multigated Acqu...
Oxaliplatin
18 Years - National Cancer Institute (NCI)
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or CholangiocarcinomaNCT01093222
Extrahepatic Bi...
Gallbladder Ade...
Gallbladder Ade...
Hilar Cholangio...
Recurrent Extra...
Recurrent Gallb...
Undifferentiate...
Unresectable Ex...
Unresectable Ga...
Erlotinib Hydro...
Sorafenib Tosyl...
18 Years - National Cancer Institute (NCI)
MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by SurgeryNCT01425879
Advanced Adult ...
Localized Non-R...
Recurrent Adult...
Recurrent Gallb...
Stage IV Distal...
Stage IV Gallbl...
Unresectable Ex...
Unresectable Ga...
Akt Inhibitor M...
Diagnostic Labo...
Pharmacological...
18 Years - National Cancer Institute (NCI)
Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by SurgeryNCT02520141
Cholangiocarcin...
Liver and Intra...
Stage III Gallb...
Stage III Intra...
Stage IIIA Gall...
Stage IIIB Gall...
Stage IV Gallbl...
Stage IVA Gallb...
Stage IVA Intra...
Stage IVB Gallb...
Stage IVB Intra...
Unresectable Ga...
Laboratory Biom...
Ramucirumab
18 Years - M.D. Anderson Cancer Center
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract CancersNCT03768414
Stage III Dista...
Stage III Gallb...
Stage III Intra...
Stage IIIA Dist...
Stage IIIA Gall...
Stage IIIA Intr...
Stage IIIB Dist...
Stage IIIB Gall...
Stage IIIB Intr...
Stage IV Distal...
Stage IV Gallbl...
Stage IV Intrah...
Stage IVA Gallb...
Stage IVB Gallb...
Unresectable Ex...
Unresectable Ga...
Unresectable In...
Cisplatin
Gemcitabine Hyd...
Nab-paclitaxel
18 Years - SWOG Cancer Research Network
Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary CancersNCT02392637
Stage III Intra...
Stage IIIA Gall...
Stage IIIB Gall...
Stage IVA Gallb...
Stage IVA Intra...
Stage IVB Gallb...
Stage IVB Intra...
Unresectable Ex...
Unresectable Ga...
Cisplatin
Gemcitabine Hyd...
Laboratory Biom...
Nab-paclitaxel
18 Years - M.D. Anderson Cancer Center
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or CholangiocarcinomaNCT01093222
Extrahepatic Bi...
Gallbladder Ade...
Gallbladder Ade...
Hilar Cholangio...
Recurrent Extra...
Recurrent Gallb...
Undifferentiate...
Unresectable Ex...
Unresectable Ga...
Erlotinib Hydro...
Sorafenib Tosyl...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: